Publicaties en klinische studies

Proefschriften

Tumorcellen opsporen en behandelen tijdens operatie prostaatkanker

Eiwit op tumorcellen opent deuren voor betere therapie en diagnostiek prostaatkanker

Palliative Systemic Therapy for Salivary Gland Cancer

Klinische studies

Overzicht PSMA klinische studies

Nederlandse publicaties

The New Editorial on EANM Focus 5 – consensus on molecular imaging and theranostics in prostate cancer proofs the multidisciplinarity character and the progress booked in this field. A nice celebration of a great event in February 2023, Seville, Spain.

Appropriate Use Criteria for Prostate-Specific Membrane Antigen (PSMA) PET Imaging

SNMMI AUC Factsheet for Prostate-Specific Membrane Antigen Imaging

Buitenlandse publicaties

European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer

[ 18F]DCFPyL PET/CT versus [ 18F]fuoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross‑over, comparative study

AlphaBet: Combination of Radium-223 and [177Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol)

Nederlandse (wetenschappelijke) samenvatting van de VISION studie (internationale registratie studie van ¹⁷⁷Lu-PSMA) – Titel: Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

Nederlandse (wetenschappelijke) samenvatting van de TheraP studie (studie die ¹⁷⁷Lu-PSMA vergeleek met cabazitaxel) – Titel: ¹⁷⁷Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

Nederlandse (wetenschappelijke) samenvatting met de overlevingsdata van de TheraP studie (studie die 177Lu-PSMA vergeleek met cabazitaxel) – Titel: TheraP: 177Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel—Overall survival after median follow-up of 3 years (ANZUP 1603)

Nederlandse (wetenschappelijke) samenvatting van de ProPSMA studie (studie die de 68Ga-PSMA PET onderzocht in patiënten met een recente diagnose hoog-risico prostaatkanker) – Titel: Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

➜ Over Stichting PSMA forum

➜ Word donateur

➜ Vergaderingen

➜ Richtlijnen en protocollen

➜ Landelijke samenwerking

➜ (Pers)berichten